Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1998-04-06
1999-12-07
Kunz, Gary L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514821, 536 2762, 560155, A61K 3170, C07H 19167, C07C22904
Patent
active
059983876
ABSTRACT:
Adenosine and xanthine deriviatives, and compositions comprising those compounds, are potent selective agonists of adenosine receptors. The derivatives and compositions are used to treat conditions, including certain cardiac arrhythmias.
REFERENCES:
patent: 3998953 (1976-12-01), Konz et al.
patent: 4364922 (1982-12-01), Berne et al.
patent: 4713455 (1987-12-01), Furrer et al.
patent: 4980379 (1990-12-01), Belardinelli et al.
patent: 5288721 (1994-02-01), Klein et al.
patent: 5736528 (1998-04-01), Belardinelli et al.
Belardinelli, L., J. Linden, R.M. Berne (1989) "The Cardiac Effects of Adenosine" Progress in Cardiovascular Diseases 32(1):73-97.
Belardinelli, L., A. Pelleg (1990) "Cardiac Electrophysiology and Pharmacology of Adenosine" Journal of Cardiovascular Electrophysiology 1(4):327-339..
Olsson, R.A., J.D. Pearson (1990) "Cardiovascular Purinoceptors"Physiological Review 70(3):761-845.
Belardinelli, L. (1993) "Adenosine System in the Heart" Drug Development Research 28:263-267.
Belardinelli, L. (1991) "Adenosine: Cardiac Electrophysiology" Pacing and Clinical Electrophysiology 14(11):1672-1680.
Jacobson, K.A. et al. (1992) "Adenosine Receptors: Pharmacology, Structure--Activity Relationships, and Therapeutic Potential" Journal of Medicinal Chemistry 35(3):407-422.
Baker Stephen
Belardinelli Luiz
Milner Peter G.
Olsson Ray
Pfister Jurg R.
Kunz Gary L.
Pochopien Donald J.
University of Florida Research Foundation Inc.
LandOfFree
Method for using A.sub.1 adenosine receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for using A.sub.1 adenosine receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for using A.sub.1 adenosine receptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-823891